A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis : First-in-human trial of ChAd63-KH

Osman, Mohamed, Mistry, Anoop orcid.org/0000-0002-6664-3725, Keding, Ada orcid.org/0000-0002-1182-887X et al. (12 more authors) (2017) A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis : First-in-human trial of ChAd63-KH. PLOS NEGLECTED TROPICAL DISEASES. e0005527. ISSN 1935-2727

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Osman et al.
Keywords: Journal Article
Dates:
  • Published: 12 May 2017
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Biology (York)
The University of York > Faculty of Sciences (York) > Centre for Immunology and Infection (CII) (York)
The University of York > Faculty of Sciences (York) > Health Sciences (York)
The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
Depositing User: Pure (York)
Date Deposited: 22 May 2017 13:30
Last Modified: 12 Jan 2020 02:23
Published Version: https://doi.org/10.1371/journal.pntd.0005527
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1371/journal.pntd.0005527

Download

Filename: journal.pntd.0005527.pdf

Description: journal.pntd.0005527

Licence: CC-BY 2.5

Share / Export

Statistics